Profile data is unavailable for this security.
About the company
Bloomage Biotechnology Corp Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of hyaluronic acid and other bioactive products. The Company's products include raw material products, medical end products, functional skin care products and functional foods. The raw material products include a series of bioactive products with hyaluronic acid as the core, which are widely used in the fields of drugs, medical devices, cosmetics, functional food and general food. The medical end products are divided into medical beauty and medicine, including ophthalmic viscoelastics, medical lubricants, soft tissue fillers, medical skin protectors and others. The functional skin care products include lotion, cream, facial mask, hand mask and others. The functional foods include hyaluronic acid water, hyaluronic acid food and others.
- Revenue in CNY (TTM)6.13bn
- Net income in CNY635.44m
- Incorporated2000
- Employees4.66k
- LocationBloomage Biotechnology Corp LtdNo.678 Tianchen StreetHigh-tech Development ZoneJI'NAN 250101ChinaCHN
- Phone+86 1 085670603
- Fax+86 1 065630000
- Websitehttps://www.bloomagebiotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bloomage Biotechnology Corp Ltd | 6.13bn | 635.44m | 30.53bn | 4.66k | 48.06 | 4.28 | -- | 4.98 | 1.32 | 1.32 | 12.73 | 14.81 | 0.731 | 1.44 | 11.60 | 1,317,143.00 | 7.45 | 11.04 | 8.63 | 12.97 | 72.57 | 76.52 | 10.20 | 16.21 | 1.86 | -- | 0.0147 | 30.33 | -4.45 | 36.91 | -38.97 | 6.93 | 43.65 | -- |
| Holder | Shares | % Held |
|---|---|---|
| China Asset Management Co., Ltd.as of 30 Sep 2023 | 23.12m | 11.70% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 5.17m | 2.62% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 4.25m | 2.15% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 3.48m | 1.76% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 1.41m | 0.72% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 1.25m | 0.63% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 922.33k | 0.47% |
| Tian Hong Asset Management Co., Ltd.as of 30 Jun 2023 | 908.67k | 0.46% |
| DSM Capital Partners LLCas of 31 Mar 2023 | 896.55k | 0.45% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2023 | 583.36k | 0.30% |
